Here are the key details to know:
1. Cantel Medical grew total sales by 13.2 percent year over year, with 8.4 percent organic growth.
2. The company’s endoscopy division increased sales by 14.8 percent for the quarter, with organic growth of 8.1 percent.
3. Cantel ended the quarter with 94.1 million in cash and $200 million in gross debt.
4. Cantel’s adjusted EBITDA increased 4.5 percent year over year.
5. Cantel’s U.S.-based business also had a strong quarter, with a 7.4 percent increase for the year.
More articles on gastroenterology:
New guidelines support fecal-microbiota transplant as 2nd-line C. diff treatment — 6 insights
Positive results from Mauna Kea’s Barrett’s Esophagus drug published — 4 insights
GI leader to know: Dr. Michael Sheffield of The Oregon Clinic Gastroenterology South
